Molecular Structure of the Phagocyte NADPH Oxidase
吞噬细胞 NADPH 氧化酶的分子结构
基本信息
- 批准号:7216290
- 负责人:
- 金额:$ 29.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-09-30 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:4-ethoxymethylene-2-phenyl-2-oxazoline-5-oneAddressAnabolismBindingCell LineCell membraneChimeric ProteinsComplexDockingEnzymesGene ExpressionGenerationsGenetic TranscriptionGoalsGrantInterleukin-9KineticsLateralMembraneMolecularMolecular StructureNADPH OxidaseNatureOxidasesPhagocytesPlayProductionProteinsRegulationRelative (related person)ResearchRoleSiteStructureSuperoxidesSystemTestingWorkbasecytochrome b558human AKAP13 proteinin vivointermolecular interactionmolecular assembly/self assemblyneutrophilneutrophil cytosol factor 40Kneutrophil cytosol factor 67Knumb proteinprogramspromoterprotein degradationprotein protein interactionrap GTP-Binding Proteinssegregationtranscription factor
项目摘要
DESCRIPTION (provided by applicant): The generation of 02- by phagocytic cells requires the assembly of a membrane-bound complex known as the NADPH oxidase, which is composed of an integral plasma membrane flavocytochrome b and four cytosolic proteins (p40 phox, p47 phox, p67 phox, and Rac2). Although progress has been made, there is limited information about how each of these proteins regulate formation of the active NADPH oxidase complex and, similarly, what turns off the system. In the previous grant period, we identified a number of protein-protein interactions among the NADPH oxidase protein components and investigated how these interactions related to assembly of the active 02- generating system. In this renewal application, we propose studies to investigate how NADPH oxidase assembly is regulated. Based on studies performed under the previous grant period, studies by others on the phagocyte NADPH oxidase, and preliminary work described here, we hypothesize that neutrophil capacity for oxidase assembly and oxidase assembly per se are regulated at several different levels, including transcription and biosynthesis of the phox proteins, molecular assembly of the active system, and lateral organization in plasma membrane domains. Consequently, appropriate NADPH oxidase activity results from integration of these multiple levels of regulation. Because of the complex nature of the oxidase, we propose to address this hypothesis by focusing this project primarily on the role of the cytosolic phox factors in oxidase regulation. Specifically, this proposal describes strategies for: 1) characterizing the promoter for p67 phox and determining what transcription factors regulate p67 phox transcription; 2) characterizing cytosolic phox protein gene expression; 3) analyzing biosynthesis of the cytosolic phox proteins to determine relative stability of these proteins and kinetics of protein turnover; 4) identifying and characterizing flavocytochrome b domains that bind p67 phox and Rac; and 5) develop cell lines expressing GFP-phox fusion proteins for use analysis of the intermolecular interactions between cytosolic oxidase proteins and the oxidase complex in vivo. The results of these studies will further our understanding of how distinct levels of regulatory input are integrated to facilitate functional assembly and activation of the phagocyte NADPH oxidase.
描述(由申请人提供):吞噬细胞产生 02- 需要组装称为 NADPH 氧化酶的膜结合复合物,该复合物由完整的质膜黄细胞色素 b 和四种胞质蛋白(p40 phox、p47 phox、p67 phox 和 Rac2)组成。尽管已经取得了进展,但关于这些蛋白质如何调节活性 NADPH 氧化酶复合物的形成以及类似地如何关闭该系统的信息有限。在之前的资助期间,我们确定了 NADPH 氧化酶蛋白质成分之间的许多蛋白质-蛋白质相互作用,并研究了这些相互作用如何与活性 02 生成系统的组装相关。在此更新应用中,我们提出研究来调查 NADPH 氧化酶组装是如何调节的。基于之前资助期间进行的研究、其他人对吞噬细胞 NADPH 氧化酶的研究以及本文描述的初步工作,我们假设中性粒细胞氧化酶组装的能力和氧化酶组装本身在几个不同的水平上受到调节,包括 phox 蛋白的转录和生物合成、活性系统的分子组装以及质膜域的横向组织。因此,适当的 NADPH 氧化酶活性是这些多级调节整合的结果。由于氧化酶的复杂性,我们建议通过将该项目主要集中在细胞质 phox 因子在氧化酶调节中的作用来解决这一假设。具体来说,该提案描述了以下策略:1)表征 p67 phox 的启动子并确定哪些转录因子调节 p67 phox 转录; 2)表征细胞质phox蛋白基因表达; 3) 分析胞质phox蛋白的生物合成以确定这些蛋白的相对稳定性和蛋白周转动力学; 4) 鉴定和表征结合 p67 phox 和 Rac 的黄素细胞色素 b 结构域; 5) 开发表达 GFP-phox 融合蛋白的细胞系,用于分析胞质氧化酶蛋白与体内氧化酶复合物之间的分子间相互作用。这些研究的结果将进一步加深我们对如何整合不同水平的调节输入以促进吞噬细胞 NADPH 氧化酶的功能组装和激活的理解。
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Superoxide production in the vasculature of lipopolysaccharide-treated rats and pigs.
脂多糖处理的大鼠和猪的脉管系统中超氧化物的产生。
- DOI:10.1097/01.shk.0000054374.88889.37
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Javesghani,Danesh;Hussain,SabahNA;Scheidel,Jonathan;Quinn,MarkT;Magder,SheldonA
- 通讯作者:Magder,SheldonA
Inhibition of peroxynitrite-mediated tyrosine nitration by a novel pyrrolopyrimidine antioxidant.
新型吡咯并嘧啶抗氧化剂抑制过氧亚硝酸盐介导的酪氨酸硝化。
- DOI:10.1016/s0014-2999(98)00399-9
- 发表时间:1998
- 期刊:
- 影响因子:5
- 作者:Rohn,TT;Quinn,MT
- 通讯作者:Quinn,MT
Cloning and sequencing of rabbit leukocyte NADPH oxidase genes reveals a unique p67phox homolog
兔白细胞 NADPH 氧化酶基因的克隆和测序揭示了独特的 p67phox 同源物
- DOI:
- 发表时间:2002
- 期刊:
- 影响因子:5.5
- 作者:Katherine A. Gauss;P. Mascolo;D. Siemsen;L. K. Nelson;P. L. Bunger;P. Pagano;M. Quinn
- 通讯作者:M. Quinn
Analysis of activation-induced conformational changes in p47phox using tryptophan fluorescence spectroscopy.
使用色氨酸荧光光谱分析 p47phox 中激活诱导的构象变化。
- DOI:10.1074/jbc.272.47.29502
- 发表时间:1997
- 期刊:
- 影响因子:0
- 作者:Swain,SD;Helgerson,SL;Davis,AR;Nelson,LK;Quinn,MT
- 通讯作者:Quinn,MT
p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II.
p47phox 通过人血管平滑肌细胞中的皮质素与细胞骨架结合:在血管紧张素 II 的 NAD(P)H 氧化酶调节中的作用。
- DOI:10.1161/01.atv.0000154141.66879.98
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Touyz,RM;Yao,G;Quinn,MT;Pagano,PJ;Schiffrin,EL
- 通讯作者:Schiffrin,EL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK T QUINN其他文献
MARK T QUINN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK T QUINN', 18)}}的其他基金
Development of Novel Therapeutics for the Treatment of Alzheimer's Disease
开发治疗阿尔茨海默病的新疗法
- 批准号:
10121243 - 财政年份:2016
- 资助金额:
$ 29.49万 - 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
- 批准号:
9100428 - 财政年份:2014
- 资助金额:
$ 29.49万 - 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
- 批准号:
8705651 - 财政年份:2014
- 资助金额:
$ 29.49万 - 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
- 批准号:
9306156 - 财政年份:2014
- 资助金额:
$ 29.49万 - 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
- 批准号:
8874236 - 财政年份:2014
- 资助金额:
$ 29.49万 - 项目类别:
MT VET COBRE II CORE A: ADMINISTRATIVE CORE
MT VET COBRE II 核心 A:管理核心
- 批准号:
8360158 - 财政年份:2011
- 资助金额:
$ 29.49万 - 项目类别:
MT VET COBRE II CORE A: ADMINISTRATIVE CORE
MT VET COBRE II 核心 A:管理核心
- 批准号:
8168412 - 财政年份:2010
- 资助金额:
$ 29.49万 - 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
- 批准号:
7902317 - 财政年份:2009
- 资助金额:
$ 29.49万 - 项目类别:
Center for Zoonotic and Emerging Infectious Diseases
人畜共患病和新发传染病中心
- 批准号:
7902316 - 财政年份:2009
- 资助金额:
$ 29.49万 - 项目类别:
MT VET COBRE CORE A: ADMINISTRATIVE CORE
MT VET COBRE 核心 A:行政核心
- 批准号:
7960521 - 财政年份:2009
- 资助金额:
$ 29.49万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Research Grant














{{item.name}}会员




